Contrary to the well-known involvement of the canonical NF-κB signalling in T1D and T2D islet inflammation [6, 31], the role of NIK and the non-canonical NF-κB signalling in diabetes pathology is unclear. This evidence concerns the gene NFKB1 and type 2 diabetes mellitus.